Autism and EMF? Plausibility of a pathophysiological link part II

Pathophysiology

Volumn 20, Issue 3, 2013, Pages 211-234

  Herbert, Martha R ^a   Sage, Cindy ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Sage Associates Inc   (United States)

Author keywords

Autism; Cellular stress; Children; EMF RFR; Environment; Fetus; Microwave; Mitochondrial dysfunction; Oscillatory synchronization; Oxidative stress; Radiofrequency; Wireless

Indexed keywords

GLUTATHIONE; MELATONIN;

ARTICLE; AUTISM; AUTONOMIC DYSFUNCTION; BRAIN BLOOD FLOW; BRAIN CELL; BRAIN ELECTROPHYSIOLOGY; BRAIN METABOLISM; BRAIN MITOCHONDRION; CELL ACTIVATION; CELL DAMAGE; DEVELOPMENTAL DISORDER; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTROMAGNETIC FIELD; EPILEPSY; EXCITOTOXICITY; GENETIC ASSOCIATION; HORMONE ACTION; HUMAN; IMMUNOPATHOLOGY; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NEUROPHYSIOLOGY; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREGNANCY OUTCOME; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; SEIZURE; SENSORY PROCESSING; SLEEP DISORDER;

EID: 84886087229     PISSN: 09284680     EISSN: 1873149X     Source Type: Journal    
DOI: 10.1016/j.pathophys.2013.08.002     Document Type: Article

References (323)

1. Wallace K.B., Starkov A.A. Mitochondrial targets of drug toxicity. Annu. Rev. Pharmacol. Toxicol. 2000, 40:353-388.
2. Thar R., Kuhl M. Propagation of electromagnetic radiation in mitochondria?. J. Theor. Biol. 2004, 230:261-270.
3. Aon M.A., Cortassa S., O'Rourke B. Mitochondrial oscillations in physiology and pathophysiology. Adv. Exp. Med. Biol. 2008, 641:98-117.
4. Khaki A.A., Tubbs R.S., Shoja M.M., Rad J.S., Khaki A., Farahani R.M., Zarrintan S., Nag T.C. The effects of an electromagnetic field on the boundary tissue of the seminiferous tubules of the rat: a light and transmission electron microscope study. Folia Morphol. (Warsz) 2006, 65:188-194.
5. Lahijani M.S., Tehrani D.M., Sabouri E. Histopathological and ultrastructural studies on the effects of electromagnetic fields on the liver of preincubated white Leghorn chicken embryo. Electromagn. Biol. Med. 2009, 28:391-413.
6. Esmekaya M.A., Aytekin E., Ozgur E., Guler G., Ergun M.A., Omeroglu S., Seyhan N. Mutagenic and morphologic impacts of 1.8GHz radiofrequency radiation on human peripheral blood lymphocytes (hPBLs) and possible protective role of pre-treatment with Ginkgo biloba (EGb 761). Sci. Total Environ. 2011, 410-411:59-64.
7. Xu S., Zhou Z., Zhang L., Yu Z., Zhang W., Wang Y., Wang X., Li M., Chen Y., Chen C., He M., Zhang G., Zhong M. Exposure to 1800MHz radiofrequency radiation induces oxidative damage to mitochondrial DNA in primary cultured neurons. Brain Res. 2010, 1311:189-196.
8. Chernysheva O.N. Effect of an alternating magnetic field of industrial frequency on the lipid composition of the rat liver. Ukr. Biokhim. Zh. 1987, 59:91-94.
9. Wang C., Cong J., Xian H., Cao X., Sun C., Wu K. The effects of electromagnetic pulse on fluidity and lipid peroxidation of mitochondrial membrane. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2002, 20:266-268.
10. Dragicevic N., Bradshaw P.C., Mamcarz M., Lin X., Wang L., Cao C., Arendash G.W. Long-term electromagnetic field treatment enhances brain mitochondrial function of both Alzheimer's transgenic mice and normal mice: a mechanism for electromagnetic field-induced cognitive benefit?. Neuroscience 2011, 185:135-149.
11. Belyaev I. Evidence for Disruption by Modulation: Role of Physical and Biological Variables in Bioeffects of Non-Thermal Microwaves for Reproducibility, Cancer Risk and Safety Standards. The BioInitiative Report 2012: A Rationale for a Biologically-based Public Exposure Standard for Electromagnetic Fields (ELF and RF) 2012, http://www.bioinitiative.org/, C. Sage, D.O. Carpenter (Eds.).
12. Giulivi C., Zhang Y.F., Omanska-Klusek A., Ross-Inta C., Wong S., Hertz-Picciotto I., Tassone F., Pessah I.N. Mitochondrial dysfunction in autism. JAMA 2010, 304:2389-2396.
13. Palmieri L., Papaleo V., Porcelli V., Scarcia P., Gaita L., Sacco R., Hager J., Rousseau F., Curatolo P., Manzi B., Militerni R., Bravaccio C., Trillo S., Schneider C., Melmed R., Elia M., Lenti C., Saccani M., Pascucci T., Puglisi-Allegra S., Reichelt K.L., Persico A.M. Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1. Mol. Psychiatry. 2010, 15:38-52.
14. Pastural E., Ritchie S., Lu Y., Jin W., Kavianpour A., Khine Su-Myat K., Heath D., Wood P.L., Fisk M., Goodenowe D.B. Novel plasma phospholipid biomarkers of autism: mitochondrial dysfunction as a putative causative mechanism. Prostaglandins Leukot Essent. Fatty Acids 2009, 81:253-264.
15. Zecavati N., Spence S.J. Neurometabolic disorders and dysfunction in autism spectrum disorders. Curr. Neurol. Neurosci. Rep. 2009, 9:129-136.
16. Rossignol D.A., Frye R.E. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol. Psychiatry. 2011, 1-25.
17. Hadjixenofontos A., Schmidt M.A., Whitehead P.L., Konidari I., Hedges D.J., Wright H.H., Abramson R.K., Menon R., Williams S.M., Cuccaro M.L., Haines J.L., Gilbert J.R., Pericak-Vance M.A., Martin E.R., McCauley J.L. Evaluating mitochondrial DNA variation in autism spectrum disorders. Ann. Hum. Genet. 2012.
18. Palmieri L., Persico A.M. Mitochondrial dysfunction in autism spectrum disorders: cause or effect?. Biochim. Biophys. Acta 2010, 1797:1130-1137.
19. Leon J., Acuna-Castroviejo D., Escames G., Tan D.X., Reiter R.J. Melatonin mitigates mitochondrial malfunction. J. Pineal Res. 2005, 38:1-9.
20. Luchetti F., Canonico B., Betti M., Arcangeletti M., Pilolli F., Piroddi M., Canesi L., Papa S., Galli F. Melatonin signaling and cell protection function. FASEB J. 2010, 24:3603-3624.
21. Limon-Pacheco J.H., Gonsebatt M.E. The glutathione system and its regulation by neurohormone melatonin in the central nervous system. Cent. Nerv. Syst. Agents Med. Chem. 2010, 10:287-297.
22. Hardeland R. Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine 2005, 27:119-130.
23. Gupta Y.K., Gupta M., Kohli K. Neuroprotective role of melatonin in oxidative stress vulnerable brain. Indian J. Physiol. Pharmacol. 2003, 47:373-386.
24. Kesari K.K., Kumar S., Behari J. 900-MHz microwave radiation promotes oxidation in rat brain. Electromagn. Biol. Med. 2011, 30:219-234.
25. Oktem F., Ozguner F., Mollaoglu H., Koyu A., Uz E. Oxidative damage in the kidney induced by 900-MHz-emitted mobile phone: protection by melatonin. Arch. Med. Res. 2005, 36:350-355.
26. Imaida K., Hagiwara A., Yoshino H., Tamano S., Sano M., Futakuchi M., Ogawa K., Asamoto M., Shirai T. Inhibitory effects of low doses of melatonin on induction of preneoplastic liver lesions in a medium-term liver bioassay in F344 rats: relation to the influence of electromagnetic near field exposure. Cancer Lett. 2000, 155:105-114.
27. Lai H., Singh N.P. Melatonin and a spin-trap compound block radiofrequency electromagnetic radiation-induced DNA strand breaks in rat brain cells. Bioelectromagnetics 1997, 18:446-454.
28. Ozguner F., Aydin G., Mollaoglu H., Gokalp O., Koyu A., Cesur G. Prevention of mobile phone induced skin tissue changes by melatonin in rat: an experimental study. Toxicol. Ind. Health 2004, 20:133-139.
29. Ozguner F., Bardak Y., Comlekci S. Protective effects of melatonin and caffeic acid phenethyl ester against retinal oxidative stress in long-term use of mobile phone: a comparative study. Mol. Cell Biochem. 2006, 282:83-88.
30. Yariktas M., Doner F., Ozguner F., Gokalp O., Dogru H., Delibas N. Nitric oxide level in the nasal and sinus mucosa after exposure to electromagnetic field. Otolaryngol. Head Neck Surg. 2005, 132:713-716.
31. Sokolovic D., Djindjic B., Nikolic J., Bjelakovic G., Pavlovic D., Kocic G., Krstic D., Cvetkovic T., Pavlovic V. Melatonin reduces oxidative stress induced by chronic exposure of microwave radiation from mobile phones in rat brain. J. Radiat. Res. 2008, 49:579-586.
32. Bellieni C.V., Tei M., Iacoponi F., Tataranno M.L., Negro S., Proietti F., Longini M., Perrone S., Buonocore G. Is newborn melatonin production influenced by magnetic fields produced by incubators?. Early Hum. Dev. 2012, 88:707-710.
33. Indredavik M.S., Vik T., Evensen K.A., Skranes J., Taraldsen G., Brubakk A.M. Perinatal risk and psychiatric outcome in adolescents born preterm with very low birth weight or term small for gestational age. J. Dev. Behav. Pediatr. 2010, 31:286-294.
34. Indredavik M.S., Vik T., Skranes J., Brubakk A.M. Positive screening results for autism in ex-preterm infants. Pediatrics 2008, 122:222. author reply 222-223.
35. Johnson S., Hollis C., Hennessy E., Kochhar P., Wolke D., Marlow N. Screening for autism in preterm children: diagnostic utility of the social communication questionnaire. Arch. Dis. Child 2011, 96:73-77.
36. Johnson S., Hollis C., Kochhar P., Hennessy E., Wolke D., Marlow N. Autism spectrum disorders in extremely preterm children. J. Pediatr. 2010, 156:525-531. e522.
37. Johnson S., Marlow N. Preterm birth and childhood psychiatric disorders. Pediatr. Res. 2011, 69:11R-18R.
38. Lampi K.M., Lehtonen L., Tran P.L., Suominen A., Lehti V., Banerjee P.N., Gissler M., Brown A.S., Sourander A. Risk of autism spectrum disorders in low birth weight and small for gestational age infants. J. Pediatr. 2012, 161:830-836.
39. Limperopoulos C. Autism spectrum disorders in survivors of extreme prematurity. Clin. Perinatol. 2009, 36:791-805. vi.
40. Limperopoulos C. Extreme prematurity, cerebellar injury, and autism. Semin. Pediatr. Neurol. 2010, 17:25-29.
41. Limperopoulos C., Bassan H., Sullivan N.R., Soul J.S., Robertson R.L., Moore M., Ringer S.A., Volpe J.J., du Plessis A.J. Positive screening for autism in ex-preterm infants: prevalence and risk factors. Pediatrics 2008, 121:758-765.
42. Matson M.L., Matson J.L., Beighley J.S. Comorbidity of physical and motor problems in children with autism. Res. Dev. Disabil. 2011, 32:2304-2308.
43. Pinto-Martin J.A., Levy S.E., Feldman J.F., Lorenz J.M., Paneth N., Whitaker A.H. Prevalence of autism spectrum disorder in adolescents born weighing <2000 grams. Pediatrics 2011, 128:883-891.
44. Rossignol D.A., Frye R.E. Melatonin in autism spectrum disorders: a systematic review and meta-analysis. Dev. Med. Child Neurol. 2011, 53:783-792.
45. Bourgeron T. The possible interplay of synaptic and clock genes in autism spectrum disorders. Cold Spring Harb. Symp. Quant. Biol. 2007, 72:645-654.
46. Pagan C., Botros H.G., Poirier K., Dumaine A., Jamain S., Moreno S., de Brouwer A., Van Esch H., Delorme R., Launay J.M., Tzschach A., Kalscheuer V., Lacombe D., Briault S., Laumonnier F., Raynaud M., van Bon B.W., Willemsen M.H., Leboyer M., Chelly J., Bourgeron T. Mutation screening of ASMT, the last enzyme of the melatonin pathway, in a large sample of patients with intellectual disability. BMC Med. Genet. 2011, 12:17.
47. Jonsson L., Ljunggren E., Bremer A., Pedersen C., Landen M., Thuresson K., Giacobini M., Melke J. Mutation screening of melatonin-related genes in patients with autism spectrum disorders. BMC Med. Genet. 2010, 3:10.
48. Melke J., Goubran Botros H., Chaste P., Betancur C., Nygren G., Anckarsater H., Rastam M., Stahlberg O., Gillberg I.C., Delorme R., Chabane N., Mouren-Simeoni M.C., Fauchereau F., Durand C.M., Chevalier F., Drouot X., Collet C., Launay J.M., Leboyer M., Gillberg C., Bourgeron T. Abnormal melatonin synthesis in autism spectrum disorders. Mol. Psychiatry. 2008, 13:90-98.
49. Chaste P., Clement N., Mercati O., Guillaume J.L., Delorme R., Botros H.G., Pagan C., Perivier S., Scheid I., Nygren G., Anckarsater H., Rastam M., Stahlberg O., Gillberg C., Serrano E., Lemiere N., Launay J.M., Mouren-Simeoni M.C., Leboyer M., Jockers R., Bourgeron T. Identification of pathway-biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general population. PLoS One 2010, 5:e11495.
50. Braam W., Keijzer H., Struijker Boudier H., Didden R., Smits M., Curfs L. CYP1A2 polymorphisms in slow melatonin metabolisers: a possible relationship with autism spectrum disorder?. J. Intellect. Disabil. Res. 2012.
51. Kuhn D.M., Arthur R.E. l-DOPA-quinone inactivates tryptophan hydroxylase and converts the enzyme to a redox-cycling quinoprotein. Brain Res. Mol. Brain Res. 1999, 73:78-84.
52. Kuhn D.M., Geddes T.J. Peroxynitrite inactivates tryptophan hydroxylase via sulfhydryl oxidation. Coincident nitration of enzyme tyrosyl residues has minimal impact on catalytic activity. J. Biol. Chem. 1999, 274:29726-29732.
53. Kuhn D.M., Sykes C.E., Geddes T.J., Jaunarajs K.L., Bishop C. Tryptophan hydroxylase 2 aggregates through disulfide cross-linking upon oxidation: possible link to serotonin deficits and non-motor symptoms in Parkinson's disease. J. Neurochem. 2011, 116:426-437.
54. Kuhn D.M., Arthur R. Molecular mechanism of the inactivation of tryptophan hydroxylase by nitric oxide: attack on critical sulfhydryls that spare the enzyme iron center. J. Neurosci. 1997, 17:7245-7251.
55. Bilbo S.D., Jones J.P., Parker W. Is autism a member of a family of diseases resulting from genetic/cultural mismatches? Implications for treatment and prevention. Autism Res. Treat. 2012, 2012. 910946.
56. Persico A.M., Van de Water J., Pardo C.A. Autism: where genetics meets the immune system. Autism Res. Treat. 2012, 2012:486359.
57. Kong S.W., Collins C.D., Shimizu-Motohashi Y., Holm I.A., Campbell M.G., Lee I.H., Brewster S.J., Hanson E., Harris H.K., Lowe K.R., Saada A., Mora A., Madison K., Hundley R., Egan J., McCarthy J., Eran A., Galdzicki M., Rappaport L., Kunkel L.M., Kohane I.S. Characteristics and predictive value of blood transcriptome signature in males with autism spectrum disorders. PLoS One 2012, 7:e49475.
58. Waly M.I., Hornig M., Trivedi M., Hodgson N., Kini R., Ohta A., Deth R. Prenatal and postnatal epigenetic programming: implications for GI, immune, and neuronal function in autism. Autism Res. Treat. 2012, 2012:190930.
59. Lintas C., Sacco R., Persico A.M. Genome-wide expression studies in autism spectrum disorder, Rett syndrome, and Down syndrome. Neurobiol. Dis. 2012, 45:57-68.
60. Patterson P.H. Maternal infection and immune involvement in autism. Trends Mol. Med. 2011.
61. Smith S.E., Li J., Garbett K., Mirnics K., Patterson P.H. Maternal immune activation alters fetal brain development through interleukin-6. J. Neurosci. 2007, 27:10695-10702.
62. Fox E., Amaral D., Van de Water J. Maternal and fetal antibrain antibodies in development and disease. Dev. Neurobiol. 2012, 72:1327-1334.
63. Soumiya H., Fukumitsu H., Furukawa S. Prenatal immune challenge compromises the normal course of neurogenesis during development of the mouse cerebral cortex. J. Neurosci. Res. 2011, 89:1575-1585.
64. Martin L.A., Ashwood P., Braunschweig D., Cabanlit M., Van de Water J., Amaral D.G. Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism. Brain Behav. Immun. 2008, 22:806-816.
65. Croen L.A., Grether J.K., Yoshida C.K., Odouli R., Van de Water J. Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study. Arch. Pediatr. Adolesc. Med. 2005, 159:151-157.
66. Bilbo S.D., Schwarz J.M. The immune system and developmental programming of brain and behavior. Front. Neuroendocrinol. 2012, 33:267-286.
67. Schwarz J.M., Bilbo S.D. Sex, glia, and development: interactions in health and disease. Horm. Behav. 2012, 62:243-253.
68. Boksa P. Effects of prenatal infection on brain development and behavior: a review of findings from animal models. Brain Behav. Immun. 2010, 24:881-897.
69. Blank M. Evidence for Stress Response (Stress Proteins). The BioInitiative Report 2012: A Rationale for a Biologically-based Public Exposure Standard for Electromagnetic Fields (ELF and RF) 2012, Section 7. http://www.bioinitiative.org/, C. Sage, D.O. Carpenter (Eds.).
70. Johannson O. Evidence for Effects on Immune Function. The BioInitiative Report 2012: A Rationale for a Biologically-based Public Exposure Standard for Electromagnetic Fields (ELF and RF) 2012, Section 8. http://www.bioinitiative.org/, C. Sage, D.O. Carpenter (Eds.).
71. Johansson O. Disturbance of the immune system by electromagnetic fields-a potentially underlying cause for cellular damage and tissue repair reduction which could lead to disease and impairment. Pathophysiology 2009, 16:157-177.
72. Johannson O. Evidence for Effects on Immune Function. BioInitiative Report: A Rationale for a Biologically-based Public Exposure Standard for Electromagnetic Fields (ELF and RF) 2007, http://bioinitiative.org/freeaccess/report/index.htm, C. Sage, D.O. Carpenter (Eds.).
73. Brown A.S., Derkits E.J. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am. J. Psychiatry. 2010, 167:261-280.
74. Atladottir H.O., Thorsen P., Ostergaard L., Schendel D.E., Lemcke S., Abdallah M., Parner E.T. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J. Autism Dev. Disord. 2010, 40:1423-1430.
75. Patterson P.H. Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav. Brain Res. 2009, 204:313-321.
76. Garbett K.A., Hsiao E.Y., Kalman S., Patterson P.H., Mirnics K. Effects of maternal immune activation on gene expression patterns in the fetal brain. Transl. Psychiatry. 2012, 2:e98.
77. Braunschweig D., Duncanson P., Boyce R., Hansen R., Ashwood P., Pessah I.N., Hertz-Picciotto I., Van de Water J. Behavioral correlates of maternal antibody status among children with autism. J. Autism Dev. Disord. 2012, 42:1435-1445.
78. Braunschweig D., Van de Water J. Maternal autoantibodies in autism. Arch. Neurol. 2012, 69:693-699.
79. Goines P., Haapanen L., Boyce R., Duncanson P., Braunschweig D., Delwiche L., Hansen R., Hertz-Picciotto I., Ashwood P., Van de Water J. Autoantibodies to cerebellum in children with autism associate with behavior. Brain Behav. Immun. 2011, 25:514-523.
80. Wills S., Cabanlit M., Bennett J., Ashwood P., Amaral D.G., Van de Water J. Detection of autoantibodies to neural cells of the cerebellum in the plasma of subjects with autism spectrum disorders. Brain Behav. Immun. 2009, 23:64-74.
81. Wills S., Rossi C.C., Bennett J., Martinez Cerdeno V., Ashwood P., Amaral D.G., Van de Water J. Further characterization of autoantibodies to GABAergic neurons in the central nervous system produced by a subset of children with autism. Mol. Autism 2011, 2:5.
82. Zimmerman A.W., Connors S.L., Matteson K.J., Lee L.C., Singer H.S., Castaneda J.A., Pearce D.A. Maternal antibrain antibodies in autism. Brain Behav. Immun. 2007, 21:351-357.
83. Aldad T.S., Gan G., Gao X.B., Taylor H.S. Fetal radiofrequency radiation exposure from 800-1900MHz-rated cellular telephones affects neurodevelopment and behavior in mice. Sci. Rep. 2012, 2:312.
84. Shi L., Fatemi S.H., Sidwell R.W., Patterson P.H. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J. Neurosci. 2003, 23:297-302.
85. Ashwood P., Enstrom A., Krakowiak P., Hertz-Picciotto I., Hansen R.L., Croen L.A., Ozonoff S., Pessah I.N., Van de Water J. Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes. J. Neuroimmunol. 2008, 204:149-153.
86. Ashwood P., Krakowiak P., Hertz-Picciotto I., Hansen R., Pessah I., Van de Water J. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav. Immun. 2011, 25:40-45.
87. Breece E., Paciotti B., Nordahl C.W., Ozonoff S., Van de Water J.A., Rogers S.J., Amaral D., Ashwood P. Myeloid dendritic cells frequencies are increased in children with autism spectrum disorder and associated with amygdala volume and repetitive behaviors. Brain Behav. Immun. 2012.
88. Heuer L., Ashwood P., Schauer J., Goines P., Krakowiak P., Hertz-Picciotto I., Hansen R., Croen L.A., Pessah I.N., Van de Water J. Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms. Autism Res. 2008, 1:275-283.
89. Careaga M., Ashwood P. Autism spectrum disorders: from immunity to behavior. Methods Mol. Biol. 2012, 934:219-240.
90. Broderick G., Craddock T.J. Systems biology of complex symptom profiles: capturing interactivity across behavior, brain and immune regulation. Brain Behav. Immun. 2012.
91. Jyonouchi H., Geng L., Streck D.L., Toruner G.A. Children with autism spectrum disorders (ASD) who exhibit chronic gastrointestinal (GI) symptoms and marked fluctuation of behavioral symptoms exhibit distinct innate immune abnormalities and transcriptional profiles of peripheral blood (PB) monocytes. J. Neuroimmunol. 2011.
92. Johansson M., Rastam M., Billstedt E., Danielsson S., Stromland K., Miller M., Gillberg C. Autism spectrum disorders and underlying brain pathology in CHARGE association. Dev. Med. Child Neurol. 2006, 48:40-50.
93. Theoharides T.C., Angelidou A., Alysandratos K.D., Zhang B., Asadi S., Francis K., Toniato E., Kalogeromitros D. Mast cell activation and autism. Biochim. Biophys. Acta 2012, 1822:34-41.
94. Theoharides T.C., Angelidou A., Alysandratos K.D., Zhang B., Asadi S., Francis K., Toniato E., Kalogeromitros D. Mast cell activation and autism. Biochim. Biophys. Acta 2010.
95. Zhang B., Asadi S., Weng Z., Sismanopoulos N., Theoharides T.C. Stimulated human mast cells secrete mitochondrial components that have autocrine and paracrine inflammatory actions. PLoS One 2012, 7:e49767.
96. Seitz H., Stinner D., Eikmann T., Herr C., Roosli M. Electromagnetic hypersensitivity (EHS) and subjective health complaints associated with electromagnetic fields of mobile phone communication-a literature review published between 2000 and 2004. Sci. Total Environ. 2005, 349:45-55.
97. Johansson O., Gangi S., Liang Y., Yoshimura K., Jing C., Liu P.Y. Cutaneous mast cells are altered in normal healthy volunteers sitting in front of ordinary TVs/PCs-results from open-field provocation experiments. J. Cutan. Pathol. 2001, 28:513-519.
98. Bakkaloglu B., Anlar B., Anlar F.Y., Oktem F., Pehlivanturk B., Unal F., Ozbesler C., Gokler B. Atopic features in early childhood autism. Eur. J. Paediatr. Neurol. 2008, 12:476-479.
99. Salford L.G., Nittby H., Persson B.R. Effects of EMF from wireless communication upon the blood-brain barrier. The BioInitiative Report 2012: A Rationale for a Biologically-based Public Exposure Standard for Electromagnetic Fields (ELF and RF) 2012, http://www.bioinitiative.org/, C. Sage, D.O. Carpenter (Eds.).
100. Bolshakov M., Alekseev S. Bursting responses of Lymnea neurons to microwave radiation. Bioelectromagnetics 1992, 13:119-129.
101. Zhao T.Y., Zou S.P., Knapp P.E. Exposure to cell phone radiation up-regulates apoptosis genes in primary cultures of neurons and astrocytes. Neurosci. Lett. 2007, 412:34-38.
102. Chan P., Eng L.F., Lee Y.L., Lin V.W. Effects of pulsed magnetic stimulation of GFAP levels in cultured astrocytes. J. Neurosci. Res. 1999, 55:238-244.
103. Ammari M., Brillaud E., Gamez C., Lecomte A., Sakly M., Abdelmelek H., de Seze R. Effect of a chronic GSM 900MHz exposure on glia in the rat brain. Biomed. Pharmacother. 2008, 62:273-281.
104. Ammari M., Gamez C., Lecomte A., Sakly M., Abdelmelek H., De Seze R. GFAP expression in the rat brain following sub-chronic exposure to a 900MHz electromagnetic field signal. Int. J. Radiat. Biol. 2010, 86:367-375.
105. Brillaud E., Piotrowski A., de Seze R. Effect of an acute 900MHz GSM exposure on glia in the rat brain: a time-dependent study. Toxicology 2007, 238:23-33.
106. Ragbetli M.C., Aydinlioglu A., Koyun N., Ragbetli C., Bektas S., Ozdemir S. The effect of mobile phone on the number of Purkinje cells: a stereological study. Int. J. Radiat. Biol. 2010, 86:548-554.
107. Albert E.N., Sherif M.F., Papadopoulos N.J. Effect of nonionizing radiation on the Purkinje cells of the uvula in squirrel monkey cerebellum. Bioelectromagnetics 1981, 2:241-246.
108. Albert E.N., Sherif M.F., Papadopoulos N.J., Slaby F.J., Monahan J. Effect of nonionizing radiation on the Purkinje cells of the rat cerebellum. Bioelectromagnetics 1981, 2:247-257.
109. Yang X., He G., Hao Y., Chen C., Li M., Wang Y., Zhang G., Yu Z. The role of the JAK2-STAT3 pathway in pro-inflammatory responses of EMF-stimulated N9 microglial cells. J. Neuroinflammation. 2010, 7:54.
110. Amaral D.G., Schumann C.M., Nordahl C.W. Neuroanatomy of autism. Trends Neurosci. 2008, 31:137-145.
111. Levitt P., Campbell D.B. The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders. J. Clin. Invest. 2009, 119:747-754.
112. Geschwind D.H., Levitt P. Autism spectrum disorders: developmental disconnection syndromes. Curr. Opin. Neurobiol. 2007, 17:103-111.
113. Anney R., Klei L., Pinto D., Regan R., Conroy J., Magalhaes T.R., Correia C., Abrahams B.S., Sykes N., Pagnamenta A.T., Almeida J., Bacchelli E., Bailey A.J., Baird G., Battaglia A., Berney T., Bolshakova N., Bolte S., Bolton P.F., Bourgeron T., Brennan S., Brian J., Carson A.R., Casallo G., Casey J., Chu S.H., Cochrane L., Corsello C., Crawford E.L., Crossett A., Dawson G., de Jonge M., Delorme R., Drmic I., Duketis E., Duque F., Estes A., Farrar P., Fernandez B.A., Folstein S.E., Fombonne E., Freitag C.M., Gilbert J., Gillberg C., Glessner J.T., Goldberg J., Green J., Guter S.J., Hakonarson H., Heron E.A., Hill M., Holt R., Howe J.L., Hughes G., Hus V., Igliozzi R., Kim C., Klauck S.M., Kolevzon A., Korvatska O., Kustanovich V., Lajonchere C.M., Lamb J.A., Laskawiec M., Leboyer M., Le Couteur A., Leventhal B.L., Lionel A.C., Liu X.Q., Lord C., Lotspeich L., Lund S.C., Maestrini E., Mahoney W., Mantoulan C., Marshall C.R., McConachie H., McDougle C.J., McGrath J., McMahon W.M., Melhem N.M., Merikangas A., Migita O., Minshew N.J., Mirza G.K., Munson J., Nelson S.F., Noakes C., Noor A., Nygren G., Oliveira G., Papanikolaou K., Parr J.R., Parrini B., Paton T., Pickles A., Piven J., Posey D.J., Poustka A., Poustka F., Prasad A., Ragoussis J., Renshaw K., Rickaby J., Roberts W., Roeder K., Roge B., Rutter M.L., Bierut L.J., Rice J.P., Salt J., Sansom K., Sato D., Segurado R., Senman L., Shah N., Sheffield V.C., Soorya L., Sousa I., Stoppioni V., Strawbridge C., Tancredi R., Tansey K., Thiruvahindrapduram B., Thompson A.P., Thomson S., Tryfon A., Tsiantis J., Van Engeland H., Vincent J.B., Volkmar F., Wallace S., Wang K., Wang Z., Wassink T.H., Wing K., Wittemeyer K., Wood S., Yaspan B.L., Zurawiecki D., Zwaigenbaum L., Betancur C., Buxbaum J.D., Cantor R.M., Cook E.H., Coon H., Cuccaro M.L., Gallagher L., Geschwind D.H., Gill M., Haines J.L., Miller J., Monaco A.P., Nurnberger J.I., Paterson A.D., Pericak-Vance M.A., Schellenberg G.D., Scherer S.W., Sutcliffe J.S., Szatmari P., Vicente A.M., Vieland V.J., Wijsman E.M., Devlin B., Ennis S., Hallmayer J. A genome-wide scan for common alleles affecting risk for autism. Hum. Mol. Genet. 2010, 19:4072-4082.
114. Casanova M.F. Neuropathological and genetic findings in autism: the significance of a putative minicolumnopathy. Neuroscientist 2006, 12:435-441.
115. Rubenstein J.L., Merzenich M.M. Model of autism: increased ratio of excitation/inhibition in key neural systems. Gene. Brain Behav. 2003, 2:255-267.
116. Herbert M.R. The neuroanatomy of autism. The Neuropsychology of Autism 2011, 47-76. Oxford University Press, New York, NY. D.A. Fein (Ed.).
117. Bauman M.L., Kemper T.L. Neuroanatomic observations of the brain in autism: a review and future directions. Int. J. Dev. Neurosci. 2005, 23:183-187.
118. Herbert M.R. Large brains in autism: the challenge of pervasive abnormality. Neuroscientist 2005, 11:417-440.
119. Laurence J.A., Fatemi S.H. Glial fibrillary acidic protein is elevated in superior frontal, parietal and cerebellar cortices of autistic subjects. Cerebellum 2005, 4:206-210.
120. Singh V.K., Warren R., Averett R., Ghaziuddin M. Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatr. Neurol. 1997, 17:88-90.
121. Fatemi S.H., Folsom T.D., Reutiman T.J., Lee S. Expression of astrocytic markers aquaporin 4 and connexin 43 is altered in brains of subjects with autism. Synapse 2008, 62:501-507.
122. Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 2005, 57:67-81.
123. Tetreault N.A., Hakeem A.Y., Jiang S., Williams B.A., Allman E., Wold B.J., Allman J.M. Microglia in the cerebral cortex in autism. J. Autism Dev. Disord. 2012, 42:2569-2584.
124. Morgan J.T., Chana G., Abramson I., Semendeferi K., Courchesne E., Everall I.P. Abnormal microglial-neuronal spatial organization in the dorsolateral prefrontal cortex in autism. Brain Res. 2012, 1456:72-81.
125. Suzuki K., Sugihara G., Ouchi Y., Nakamura K., Futatsubashi M. Microglial activation in young adults with Autism spectrum disorder. JAMA Psychiatry. 2013, 70:49-58.
126. Garbett K., Ebert P.J., Mitchell A., Lintas C., Manzi B., Mirnics K., Persico A.M. Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiol. Dis. 2008, 30:303-311.
127. Voineagu I., Wang X., Johnston P., Lowe J.K., Tian Y., Horvath S., Mill J., Cantor R.M., Blencowe B.J., Geschwind D.H. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 2011, 474:380-384.
128. Baron-Cohen S., Ring H.A., Bullmore E.T., Wheelwright S., Ashwin C., Williams S.C. The amygdala theory of autism. Neurosci. Biobehav. Rev. 2000, 24:355-364.
129. Dziobek I., Bahnemann M., Convit A., Heekeren H.R. The role of the fusiform-amygdala system in the pathophysiology of autism. Arch. Gen. Psychiatry. 2010, 67:397-405.
130. Hall G.B., Doyle K.A., Goldberg J., West D., Szatmari P. Amygdala engagement in response to subthreshold presentations of anxious face stimuli in adults with autism spectrum disorders: preliminary insights. PLoS One 2010, 5:e10804.
131. Mercadante M.T., Cysneiros R.M., Schwartzman J.S., Arida R.M., Cavalheiro E.A., Scorza F.A. Neurogenesis in the amygdala: a new etiologic hypothesis of autism?. Med. Hypotheses 2008, 70:352-357.
132. Nordahl C.W., Scholz R., Yang X., Buonocore M.H., Simon T., Rogers S., Amaral D.G. Increased rate of amygdala growth in children aged 2 to 4 years with autism spectrum disorders: a longitudinal study. Arch. Gen. Psychiatry. 2012, 69:53-61.
133. Otsuka H., Harada M., Mori K., Hisaoka S., Nishitani H. Brain metabolites in the hippocampus-amygdala region and cerebellum in autism: an 1H-MR spectroscopy study. Neuroradiology 1999, 41:517-519.
134. Schulkin J. Autism and the amygdala: an endocrine hypothesis. Brain Cogn. 2007, 65:87-99.
135. Schumann C.M., Amaral D.G. Stereological analysis of amygdala neuron number in autism. J. Neurosci. 2006, 26:7674-7679.
136. Schumann C.M., Barnes C.C., Lord C., Courchesne E. Amygdala enlargement in toddlers with autism related to severity of social and communication impairments. Biol. Psychiatry. 2009, 66:942-949.
137. Truitt W.A., Sajdyk T.J., Dietrich A.D., Oberlin B., McDougle C.J., Shekhar A. From anxiety to autism: spectrum of abnormal social behaviors modeled by progressive disruption of inhibitory neuronal function in the basolateral amygdala in Wistar rats. Psychopharmacology (Berl) 2007, 191:107-118.
138. Zirlinger M., Anderson D. Molecular dissection of the amygdala and its relevance to autism. Gene. Brain Behav. 2003, 2:282-294.
139. Johnson R.T., Breedlove S.M., Jordan C.L. Astrocytes in the amygdala. Vitam. Horm. 2010, 82:23-45.
140. Anitha A., Nakamura K., Thanseem I., Matsuzaki H., Miyachi T., Tsujii M., Iwata Y., Suzuki K., Sugiyama T., Mori N. Downregulation of the expression of mitochondrial electron transport complex genes in autism brains. Brain Pathol. 2012.
141. Chauhan A., Gu F., Essa M.M., Wegiel J., Kaur K., Ted Brown W., Chauhan V. Brain region-specific deficit in mitochondrial electron transport chain complexes in children with autism. J. Neurochem. 2011.
142. Chauhan A., Audhya T., Chauhan V. Brain region-specific glutathione redox imbalance in autism. Neurochem. Res. 2012, 37:1681-1689.
143. Rose S., Melnyk S., Pavliv O., Bai S., Nick T.G., Frye R.E., James S.J. Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain. Transl. Psychiatry. 2012, 2:e134.
144. Sajdel-Sulkowska E.M., Xu M., Koibuchi N. Increase in cerebellar neurotrophin-3 and oxidative stress markers in autism. Cerebellum 2009, 8:366-372.
145. Whitney E.R., Kemper T.L., Rosene D.L., Bauman M.L., Blatt G.J. Density of cerebellar basket and stellate cells in autism: evidence for a late developmental loss of Purkinje cells. J. Neurosci. Res. 2009, 87:2245-2254.
146. Whitney E.R., Kemper T.L., Bauman M.L., Rosene D.L., Blatt G.J. Cerebellar Purkinje cells are reduced in a subpopulation of autistic brains: a stereological experiment using calbindin-D28k. Cerebellum 2008, 7:406-416.
147. Shi L., Smith S.E., Malkova N., Tse D., Su Y., Patterson P.H. Activation of the maternal immune system alters cerebellar development in the offspring. Brain Behav. Immun. 2009, 23:116-123.
148. Blatt G.J., Fatemi S.H. Alterations in GABAergic biomarkers in the autism brain: research findings and clinical implications. Anat. Rec. (Hoboken) 2011, 294:1646-1652.
149. Fatemi S.H., Halt A.R., Realmuto G., Earle J., Kist D.A., Thuras P., Merz A. Purkinje cell size is reduced in cerebellum of patients with autism. Cell Mol. Neurobiol. 2002, 22:171-175.
150. Fatemi S.H., Aldinger K.A., Ashwood P., Bauman M.L., Blaha C.D., Blatt G.J., Chauhan A., Chauhan V., Dager S.R., Dickson P.E., Estes A.M., Goldowitz D., Heck D.H., Kemper T.L., King B.H., Martin L.A., Millen K.J., Mittleman G., Mosconi M.W., Persico A.M., Sweeney J.A., Webb S.J., Welsh J.P. Consensus paper: pathological role of the cerebellum in autism. Cerebellum 2012.
151. Yip J., Soghomonian J.J., Blatt G.J. Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: pathophysiological implications. Acta Neuropathol. 2007, 113:559-568.
152. Yip J., Soghomonian J.J., Blatt G.J. Increased GAD67 mRNA expression in cerebellar interneurons in autism: implications for Purkinje cell dysfunction. J. Neurosci. Res. 2008, 86:525-530.
153. Yip J., Soghomonian J.J., Blatt G.J. Decreased GAD65 mRNA levels in select subpopulations of neurons in the cerebellar dentate nuclei in autism: an in situ hybridization study. Autism Res. 2009, 2:50-59.
154. Dager S.R., Friedman S.D., Petropoulos H., Shaw D.W.W. Imaging Evidence for Pathological Brain Development in Autism Spectrum Disorders 2008, Humana Press, Totowa, NJ.
155. Bode M.K., Mattila M.L., Kiviniemi V., Rahko J., Moilanen I., Ebeling H., Tervonen O., Nikkinen J. White matter in autism spectrum disorders-evidence of impaired fiber formation. Acta Radiol. 2011, 52:1169-1174.
156. Cascio C., Gribbin M., Gouttard S., Smith R.G., Jomier M., Field S., Graves M., Hazlett H.C., Muller K., Gerig G., Piven J. Fractional anisotropy distributions in 2- to 6-year-old children with autism. J. Intellect. Disabil. Res. 2012.
157. Mak-Fan K.M., Morris D., Vidal J., Anagnostou E., Roberts W., Taylor M.J. White matter and development in children with an autism spectrum disorder. Autism 2012.
158. Travers B.G., Adluru N., Ennis C., Tromp do P.M., Destiche D., Doran S., Bigler E.D., Lange N., Lainhart J.E., Alexander A.L. Diffusion tensor imaging in autism spectrum disorder: a review. Autism Res. 2012, 5:289-313.
159. Walker L., Gozzi M., Lenroot R., Thurm A., Behseta B., Swedo S., Pierpaoli C. Diffusion tensor imaging in young children with autism: biological effects and potential confounds. Biol. Psychiatry. 2012, 72:1043-1051.
160. Wolff J.J., Gu H., Gerig G., Elison J.T., Styner M., Gouttard S., Botteron K.N., Dager S.R., Dawson G., Estes A.M., Evans A.C., Hazlett H.C., Kostopoulos P., McKinstry R.C., Paterson S.J., Schultz R.T., Zwaigenbaum L., Piven J. Differences in white matter fiber tract development present from 6 to 24 months in infants with autism. Am. J. Psychiatry. 2012, 169:589-600.
161. Sundaram S.K., Kumar A., Makki M.I., Behen M.E., Chugani H.T., Chugani D.C. Diffusion tensor imaging of frontal lobe in autism spectrum disorder. Cereb. Cortex. 2008, 18:2659-2665.
162. Herbert M.R. Why aren't we there yet? Valuable but incomplete measures of brain changes in babies with autism 2012.
163. Muller R.A., Kleinhans N., Kemmotsu N., Pierce K., Courchesne E. Abnormal variability and distribution of functional maps in autism: an FMRI study of visuomotor learning. Am. J. Psychiatry. 2003, 160:1847-1862.
164. Dinstein I., Heeger D.J., Lorenzi L., Minshew N.J., Malach R., Behrmann M. Unreliable evoked responses in autism. Neuron 2012, 75:981-991.
165. Carrubba S., Marino A.A. The effects of low-frequency environmental-strength electromagnetic fields on brain electrical activity: a critical review of the literature. Electromagn. Biol. Med. 2008, 27:83-101.
166. Marino A.A., Wolcott R.M., Chervenak R., Jourd'heuil F., Nilsen E., Frilot C., Pruett S.B. Coincident nonlinear changes in the endocrine and immune systems due to low-frequency magnetic fields. Neuroimmunomodulation 2001, 9:65-77.
167. Marino A.A., Frilot C. Comment on "proposed test for detection of nonlinear responses in biological preparations exposed to RF energy". Bioelectromagnetics 2003, 24:70-72. discussion 73.
168. Carrubba S., Frilot C., Chesson A., Marino A.A. Detection of nonlinear event-related potentials. J. Neurosci. Methods 2006, 157:39-47.
169. Carrubba S., Minagar A., Chesson A.L., Frilot C., Marino A.A. Increased determinism in brain electrical activity occurs in association with multiple sclerosis. Neurol. Res. 2012, 34:286-290.
170. Marino A.A., Nilsen E., Frilot C. Nonlinear changes in brain electrical activity due to cell phone radiation. Bioelectromagnetics 2003, 24:339-346.
171. Marino A.A., Wolcott R.M., Chervenak R., Jourd'heuil F., Nilsen E., Frilot C. Nonlinear determinism in the immune system. In vivo influence of electromagnetic fields on different functions of murine lymphocyte subpopulations. Immunol. Invest. 2001, 30:313-334.
172. Marino A.A., Wolcott R.M., Chervenak R., Jourd'heuil F., Nilsen E., Frilot C. Nonlinear dynamical law governs magnetic field induced changes in lymphoid phenotype. Bioelectromagnetics 2001, 22:529-546.
173. Carrubba S., Frilot C., Chesson A.L., Marino A.A. Nonlinear EEG activation evoked by low-strength low-frequency magnetic fields. Neurosci. Lett. 2007, 417:212-216.
174. Marino A.A., Wolcott R.M., Chervenak R., Jourd'Heuil F., Nilsen E., Frilot C. Nonlinear response of the immune system to power-frequency magnetic fields. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000, 279:R761-R768.
175. Bachmann M., Kalda J., Lass J., Tuulik V., Sakki M., Hinrikus H. Non-linear analysis of the electroencephalogram for detecting effects of low-level electromagnetic fields. Med. Biol. Eng. Comput. 2005, 43:142-149.
176. Kuhn S., Lott U., Kramer A., Kuster N. Assessment of Human Exposure to Electromagnetic Radiation from Wireless Devices in Home and Office Environments 2012, http://www.who.int/peh-emf/meetings/archive/bsw_kuster.pdf.
177. Bellieni C.V., Pinto I., Bogi A., Zoppetti N., Andreuccetti D., Buonocore G. Exposure to electromagnetic fields from laptop use of "laptop" computers. Arch. Environ. Occup. Health 2012, 67:31-36.
178. Theberge J. Perfusion magnetic resonance imaging in psychiatry. Top. Magn. Reson. Imaging 2008, 19:111-130.
179. George M.S., Costa D.C., Kouris K., Ring H.A., Ell P.J. Cerebral blood flow abnormalities in adults with infantile autism. J. Nerv. Ment. Dis. 1992, 180:413-417.
180. Gupta S., Ratnam B. Cerebral perfusion abnormalities in children with autism and mental retardation a segmental quantitative SPECT Study. Indian Pediatr. 2009, 46:161-164.
181. Degirmenci B., Miral S., Kaya G.C., Iyilikci L., Arslan G., Baykara A., Evren I., Durak H. Technetium-99m HMPAO brain SPECT in autistic children and their families. Psychiatry. Res. 2008, 162:236-243.
182. Wilcox J., Tsuang M.T., Ledger E., Algeo J., Schnurr T. Brain perfusion in autism varies with age. Neuropsychobiology 2002, 46:13-16.
183. Galuska L., Szakall S.J., Emri M., Olah R., Varga J., Garai I., Kollar J., Pataki I., Tron L. PET and SPECT scans in autistic children. Orv. Hetil. 2002, 143:1302-1304.
184. Ohnishi T., Matsuda H., Hashimoto T., Kunihiro T., Nishikawa M., Uema T., Sasaki M. Abnormal regional cerebral blood flow in childhood autism. Brain 2000, 123(Pt 9):1838-1844.
185. Boddaert N., Chabane N., Barthelemy C., Bourgeois M., Poline J.B., Brunelle F., Samson Y., Zilbovicius M. Bitemporal lobe dysfonction in infantile autism: positron emission tomography study. J. Radiol. 2002, 83:1829-1833.
186. Burroni L., Orsi A., Monti L., Hayek Y., Rocchi R., Vattimo A.G. Regional cerebral blood flow in childhood autism: a SPET study with SPM evaluation. Nucl. Med. Commun. 2008, 29:150-156.
187. Hashimoto T., Sasaki M., Fukumizu M., Hanaoka S., Sugai K., Matsuda H. Single-photon emission computed tomography of the brain in autism: effect of the developmental level. Pediatr. Neurol. 2000, 23:416-420.
188. Ryu Y.H., Lee J.D., Yoon P.H., Kim D.I., Lee H.B., Shin Y.J. Perfusion impairments in infantile autism on technetium-99m ethyl cysteinate dimer brain single-photon emission tomography: comparison with findings on magnetic resonance imaging. Eur. J. Nucl. Med. 1999, 26:253-259.
189. Starkstein S.E., Vazquez S., Vrancic D., Nanclares V., Manes F., Piven J., Plebst C. SPECT findings in mentally retarded autistic individuals. J. Neuropsychiatry. Clin. Neurosci. 2000, 12:370-375.
190. Zilbovicius M., Boddaert N., Belin P., Poline J.B., Remy P., Mangin J.F., Thivard L., Barthelemy C., Samson Y. Temporal lobe dysfunction in childhood autism: a PET study. Positron emission tomography. Am. J. Psychiatry. 2000, 157:1988-1993.
191. Ito H., Mori K., Hashimoto T., Miyazaki M., Hori A., Kagami S., Kuroda Y. Findings of brain 99mTc-ECD SPECT in high-functioning autism-3-dimensional stereotactic ROI template analysis of brain SPECT. J. Med. Invest. 2005, 52:49-56.
192. Volkow N.D., Tomasi D., Wang G.J., Vaska P., Fowler J.S., Telang F., Alexoff D., Logan J., Wong C. Effects of cell phone radiofrequency signal exposure on brain glucose metabolism. JAMA 2011, 305:808-813.
193. Kwon M.S., Vorobyev V., Kannala S., Laine M., Rinne J.O., Toivonen T., Johansson J., Teras M., Lindholm H., Alanko T., Hamalainen H. GSM mobile phone radiation suppresses brain glucose metabolism. J. Cereb. Blood Flow Metab. 2011, 31:2293-2301.
194. Tasker J.G., Oliet S.H., Bains J.S., Brown C.H., Stern J.E. Glial regulation of neuronal function: from synapse to systems physiology. J. Neuroendocrinol. 2012, 24:566-576.
195. Eroglu C., Barres B.A. Regulation of synaptic connectivity by glia. Nature 2010, 468:223-231.
196. Bilbo S.D., Schwarz J.M. Early-life programming of later-life brain and behavior: a critical role for the immune system. Front. Behav. Neurosci. 2009, 3:14.
197. Fields R.D. Advances in understanding neuron-glia interactions. Neuron. Glia. Biol. 2006, 2:23-26.
198. Pascual O., Ben Achour S., Rostaing P., Triller A., Bessis A. Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission. PNAS 2012, 109:E197-E205.
199. Rodgers K.M., Hutchinson M.R., Northcutt A., Maier S.F., Watkins L.R., Barth D.S. The cortical innate immune response increases local neuronal excitability leading to seizures. Brain 2009, 132:2478-2486.
200. Gardoni F., Boraso M., Zianni E., Corsini E., Galli C.L., Cattabeni F., Marinovich M., Di Luca M., Viviani B. Distribution of interleukin-1 receptor complex at the synaptic membrane driven by interleukin-1beta and NMDA stimulation. J. Neuroinflammation 2011, 8:14.
201. Vezzani A., French J., Bartfai T., Baram T.Z. The role of inflammation in epilepsy. Nat. Rev. Neurol. 2011, 7:31-40.
202. Mihaly A., Bozoky B. Immunohistochemical localization of extravasated serum albumin in the hippocampus of human subjects with partial and generalized epilepsies and epileptiform convulsions. Acta Neuropathol. 1984, 65:25-34.
203. Librizzi L., Noe F., Vezzani A., de Curtis M., Ravizza T. Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage. Ann. Neurol. 2012, 72:82-90.
204. Marchi N., Teng Q., Ghosh C., Fan Q., Nguyen M.T., Desai N.K., Bawa H., Rasmussen P., Masaryk T.K., Janigro D. Blood-brain barrier damage, but not parenchymal white blood cells, is a hallmark of seizure activity. Brain Res. 2010, 1353:176-186.
205. van Vliet E.A., da Costa Araujo S., Redeker S., van Schaik R., Aronica E., Gorter J.A. Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain 2007, 130:521-534.
206. Yan E., Castillo-Melendez M., Smythe G., Walker D. Quinolinic acid promotes albumin deposition in Purkinje cell, astrocytic activation and lipid peroxidation in fetal brain. Neuroscience 2005, 134:867-875.
207. Tore F., dulou P., Haro E., Veyret B., Aubineau P. Effect of 2h GSM-900 microwave exposures at 2.0, 0.5 and 0.12W/kg on plasma protein extravasation in rat brain and dura mater 2002.
208. Tore F., Dulou P., Hoaro E., Veyret B., Aubineau P. Two-hour exposure to 2-W/kg, 900-MHZ GSM microwaves induces plasma protein extravasation in rat brain and dura mater 2001.
209. Vecchio F., Tombini M., Buffo P., Assenza G., Pellegrino G., Benvenga A., Babiloni C., Rossini P.M. Mobile phone emission increases inter-hemispheric functional coupling of electroencephalographic alpha rhythms in epileptic patients. Int. J. Psychophysiol. 2012, 84:164-171.
210. Tombini M., Pellegrino G., Pasqualetti P., Assenza G., Benvenga A., Fabrizio E., Rossini P.M. Mobile phone emissions modulate brain excitability in patients with focal epilepsy. Brain Stimul. 2012.
211. Carballo-Quintas M., Martinez-Silva I., Cadarso-Suarez C., Alvarez-Figueiras M., Ares-Pena F.J., Lopez-Martin E. A study of neurotoxic biomarkers, c-fos and GFAP after acute exposure to GSM radiation at 900MHz in the picrotoxin model of rat brains. Neurotoxicology 2011, 32:478-494.
212. Varro P., Szemerszky R., Bardos G., Vilagi I. Changes in synaptic efficacy and seizure susceptibility in rat brain slices following extremely low-frequency electromagnetic field exposure. Bioelectromagnetics 2009, 30:631-640.
213. St-Pierre L.S., Parker G.H., Bubenik G.A., Persinger M.A. Enhanced mortality of rat pups following inductions of epileptic seizures after perinatal exposures to 5nT, 7Hz magnetic fields. Life Sci. 2007, 81:1496-1500.
214. Buckley A.W., Rodriguez A.J., Jennison K., Buckley J., Thurm A., Sato S., Swedo S. Rapid eye movement sleep percentage in children with autism compared with children with developmental delay and typical development. Arch. Pediatr. Adolesc. Med. 2010, 164:1032-1037.
215. Giannotti F., Cortesi F., Cerquiglini A., Vagnoni C., Valente D. Sleep in children with autism with and without autistic regression. J. Sleep Res. 2011, 20:338-347.
216. Borbely A.A., Huber R., Graf T., Fuchs B., Gallmann E., Achermann P. Pulsed high-frequency electromagnetic field affects human sleep and sleep electroencephalogram. Neurosci. Lett. 1999, 275:207-210.
217. Huber R., Schuderer J., Graf T., Jutz K., Borbely A.A., Kuster N., Achermann P. Radio frequency electromagnetic field exposure in humans: estimation of SAR distribution in the brain, effects on sleep and heart rate. Bioelectromagnetics 2003, 24:262-276.
218. Clinton J.M., Davis C.J., Zielinski M.R., Jewett K.A., Krueger J.M. Biochemical regulation of sleep and sleep biomarkers. J. Clin. Sleep Med. 2011, 7:S38-S42.
219. Sun L., Grutzner C., Bolte S., Wibral M., Tozman T., Schlitt S., Poustka F., Singer W., Freitag C.M., Uhlhaas P.J. Impaired gamma-band activity during perceptual organization in adults with autism spectrum disorders: evidence for dysfunctional network activity in frontal-posterior cortices. J. Neurosci. 2012, 32:9563-9573.
220. Rojas D.C., Maharajh K., Teale P., Rogers S.J. Reduced neural synchronization of gamma-band MEG oscillations in first-degree relatives of children with autism. BMC Psychiatry. 2008, 8:66.
221. Rippon G., Brock J., Brown C., Boucher J. Disordered connectivity in the autistic brain: challenges for the "new psychophysiology". Int. J. Psychophysiol. 2007, 63:164-172.
222. Tierney A.L., Gabard-Durnam L., Vogel-Farley V., Tager-Flusberg H., Nelson C.A. Developmental trajectories of resting EEG power: an endophenotype of autism spectrum disorder. PLoS One 2012, 7:e39127.
223. Orekhova E.V., Stroganova T.A., Nygren G., Tsetlin M.M., Posikera I.N., Gillberg C., Elam M. Excess of high frequency electroencephalogram oscillations in boys with autism. Biol. Psychiatry. 2007, 62:1022-1029.
224. Muller R.A. From loci to networks and back again: anomalies in the study of autism. Ann. N. Y. Acad. Sci. 2008, 1145:300-315.
225. Muller R.A., Shih P., Keehn B., Deyoe J.R., Leyden K.M., Shukla D.K. Underconnected, but how? A survey of functional connectivity MRI studies in autism spectrum disorders. Cereb. Cortex. 2011, 21:2233-2243.
226. Wass S. Distortions and disconnections: disrupted brain connectivity in autism. Brain Cogn. 2011, 75:18-28.
227. Just M.A., Cherkassky V.L., Keller T.A., Minshew N.J. Cortical activation and synchronization during sentence comprehension in high-functioning autism: evidence of underconnectivity. Brain 2004, 127:1811-1821.
228. Duffy F.H., Als H. A stable pattern of EEG spectral coherence distinguishes children with autism from neuro-typical controls-a large case control study. BMC Med. 2012, 10:64.
229. Isler J.R., Martien K.M., Grieve P.G., Stark R.I., Herbert M.R. Reduced functional connectivity in visual evoked potentials in children with autism spectrum disorder. Clin. Neurophysiol. 2010.
230. Murias M., Swanson J.M., Srinivasan R. Functional connectivity of frontal cortex in healthy and ADHD children reflected in EEG coherence. Cereb. Cortex. 2007, 17:1788-1799.
231. Murias M., Webb S.J., Greenson J., Dawson G. Resting state cortical connectivity reflected in EEG coherence in individuals with autism. Biol. Psychiatry. 2007, 62:270-273.
232. Coben R., Clarke A.R., Hudspeth W., Barry R.J. EEG power and coherence in autistic spectrum disorder. Clin. Neurophysiol. 2008, 119:1002-1009.
233. Lai M.C., Lombardo M.V., Chakrabarti B., Sadek S.A., Pasco G., Wheelwright S.J., Bullmore E.T., Baron-Cohen S., Suckling J. A shift to randomness of brain oscillations in people with autism. Biol. Psychiatry. 2010, 68:1092-1099.
234. Catarino A., Churches O., Baron-Cohen S., Andrade A., Ring H. Atypical EEG complexity in autism spectrum conditions: a multiscale entropy analysis. Clin. Neurophysiol. 2011, 122:2375-2383.
235. Mathewson K.J., Jetha M.K., Drmic I.E., Bryson S.E., Goldberg J.O., Schmidt L.A. Regional EEG alpha power, coherence, and behavioral symptomatology in autism spectrum disorder. Clin. Neurophysiol. 2012, 123:1798-1809.
236. Ahmadlou M., Adeli H., Adeli A. Fractality and a wavelet-chaos-neural network methodology for EEG-based diagnosis of autistic spectrum disorder. J. Clin. Neurophysiol. 2010, 27:328-333.
237. Khan S., Gramfort A., Shetty N.R., Kitzbichler M.G., Ganesan S., Moran J.M., Lee S.M., Gabrieli J.D., Tager-Flusberg H.B., Joseph R.M., Herbert M.R., Hamalainen M.S., Kenet T. Local and long-range functional connectivity is reduced in concert in autism spectrum disorders. PNAS 2013.
238. Hinrikus H., Bachmann M., Lass J., Tomson R., Tuulik V. Effect of 7, 14 and 21Hz modulated 450MHz microwave radiation on human electroencephalographic rhythms. Int. J. Radiat. Biol. 2008, 84:69-79.
239. Marino A.A., Carrubba S. The effects of mobile-phone electromagnetic fields on brain electrical activity: a critical analysis of the literature. Electromagn. Biol. Med. 2009, 28:250-274.
240. Vecchio F., Babiloni C., Ferreri F., Curcio G., Fini R., Del Percio C., Rossini P.M. Mobile phone emission modulates interhemispheric functional coupling of EEG alpha rhythms. Eur. J. Neurosci. 2007, 25:1908-1913.
241. Tattersall J.E., Scott I.R., Wood S.J., Nettell J.J., Bevir M.K., Wang Z., Somasiri N.P., Chen X. Effects of low intensity radiofrequency electromagnetic fields on electrical activity in rat hippocampal slices. Brain Res. 2001, 904:43-53.
242. Hountala C.D., Maganioti A.E., Papageorgiou C.C., Nanou E.D., Kyprianou M.A., Tsiafakis V.G., Rabavilas A.D., Capsalis C.N. The spectral power coherence of the EEG under different EMF conditions. Neurosci. Lett. 2008, 441:188-192.
243. Bachmann M., Lass J., Kalda J., Sakki M., Tomson R., Tuulik V., Hinrikus H. Integration of differences in EEG analysis reveals changes in human EEG caused by microwave. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2006, 1:1597-1600.
244. Robledo J., Donnellan A.M., Strandt-Conroy K. An exploration of sensory and movement differences from the perspective of individuals with autism. Front. Integr. Neurosci. 2012, 6:107.
245. Perry W., Minassian A., Lopez B., Maron L., Lincoln A. Sensorimotor gating deficits in adults with autism. Biol. Psychiatry. 2007, 61:482-486.
246. Sacco R., Curatolo P., Manzi B., Militerni R., Bravaccio C., Frolli A., Lenti C., Saccani M., Elia M., Reichelt K.L., Pascucci T., Puglisi-Allegra S., Persico A.M. Principal pathogenetic components and biological endophenotypes in autism spectrum disorders. Autism Res. 2010, 3:237-252.
247. Kenet T. Sensory functions in ASD. The Neuropsychology of Autism 2011, 215-224. Oxford University Press, New York. D. Fein (Ed.).
248. Marco E.J., Hinkley L.B., Hill S.S., Nagarajan S.S. Sensory processing in autism: a review of neurophysiologic findings. Pediatr. Res. 2011, 69:48R-54R.
249. Kenet T., Froemke R.C., Schreiner C.E., Pessah I.N., Merzenich M.M. Perinatal exposure to a noncoplanar polychlorinated biphenyl alters tonotopy, receptive fields, and plasticity in rat primary auditory cortex. PNAS 2007, 104:7646-7651.
250. Pessah I.N., Lein P.J. Evidence for environmental susceptibility in autism: what we need to know about gene x environment interactions. Humana 2008.
251. Stamou M., Streifel K.M., Goines P.E., Lein P.J. Neuronal connectivity as a convergent target of gene-environment interactions that confer risk for autism spectrum disorders. Neurotoxicol. Teratol. 2012.
252. Andrzejak R., Poreba R., Poreba M., Derkacz A., Skalik R., Gac P., Beck B., Steinmetz-Beck A., Pilecki W. The influence of the call with a mobile phone on heart rate variability parameters in healthy volunteers. Ind. Health 2008, 46:409-417.
253. Szmigielski S., Bortkiewicz A., Gadzicka E., Zmyslony M., Kubacki R. Alteration of diurnal rhythms of blood pressure and heart rate to workers exposed to radiofrequency electromagnetic fields. Blood Press. Monit. 1998, 3:323-330.
254. Bortkiewicz A., Gadzicka E., Zmyslony M., Szymczak W. Neurovegetative disturbances in workers exposed to 50Hz electromagnetic fields. Int. J. Occup. Med. Environ. Health 2006, 19:53-60.
255. Graham C., Cook M.R., Sastre A., Gerkovich M.M., Kavet R. Cardiac autonomic control mechanisms in power-frequency magnetic fields: a multistudy analysis. Environ. Health. Perspect. 2000, 108:737-742.
256. Saunders R.D., Jefferys J.G. A neurobiological basis for ELF guidelines. Health Phys. 2007, 92:596-603.
257. Buchner K., Eger H. Changes of clinically important neurotransmitters under the Influence of modulated RF fields-a long-term study under real-life conditions (translated; original study in German). Umwelt-Medizin-Gesellschaft 2011, 24:44-57.
258. Bellieni C.V., Acampa M., Maffei M., Maffei S., Perrone S., Pinto I., Stacchini N., Buonocore G. Electromagnetic fields produced by incubators influence heart rate variability in newborns. Arch. Dis. Child Fetal. Neonatal. Ed. 2008, 93:F298-F301.
259. Witter F.R., Zimmerman A.W., Reichmann J.P., Connors S.L. In utero beta 2 adrenergic agonist exposure and adverse neurophysiologic and behavioral outcomes. Am. J. Obstet. Gynecol. 2009, 201:553-559.
260. Anderson C.J., Colombo J. Larger tonic pupil size in young children with autism spectrum disorder. Dev. Psychobiol. 2009, 51:207-211.
261. Anderson C.J., Colombo J., Unruh K.E. Pupil and salivary indicators of autonomic dysfunction in autism spectrum disorder. Dev. Psychobiol. 2012.
262. Daluwatte C., Miles J.H., Christ S.E., Beversdorf D.Q., Takahashi T.N., Yao G. Atypical pupillary light reflex and heart rate variability in children with autism spectrum disorder. J. Autism Dev. Disord. 2012.
263. Ming X., Bain J.M., Smith D., Brimacombe M., Gold von-Simson G., Axelrod F.B. Assessing autonomic dysfunction symptoms in children: a pilot study. J. Child Neurol. 2011, 26:420-427.
264. Hirstein W., Iversen P., Ramachandran V.S. Autonomic responses of autistic children to people and objects. Proc. Biol. Sci. 2001, 268:1883-1888.
265. Toichi M., Kamio Y. Paradoxical autonomic response to mental tasks in autism. J. Autism Dev. Disord. 2003, 33:417-426.
266. Ming X., Julu P.O., Brimacombe M., Connor S., Daniels M.L. Reduced cardiac parasympathetic activity in children with autism. Brain Dev. 2005, 27:509-516.
267. Mathewson K.J., Drmic I.E., Jetha M.K., Bryson S.E., Goldberg J.O., Hall G.B., Santesso D.L., Segalowitz S.J., Schmidt L.A. Behavioral and cardiac responses to emotional stroop in adults with autism spectrum disorders: influence of medication. Autism Res. 2011, 4:98-108.
268. Cheshire W.P. Highlights in clinical autonomic neuroscience: new insights into autonomic dysfunction in autism. Auton. Neurosci. 2012, 171:4-7.
269. Chang M.C., Parham L.D., Blanche E.I., Schell A., Chou C.P., Dawson M., Clark F. Autonomic and behavioral responses of children with autism to auditory stimuli. Am. J. Occup. Ther. 2012, 66:567-576.
270. Narayanan A., White C.A., Saklayen S., Scaduto M.J., Carpenter A.L., Abduljalil A., Schmalbrock P., Beversdorf D.Q. Effect of propranolol on functional connectivity in autism spectrum disorder-a pilot study. Brain Imaging Behav. 2010, 4:189-197.
271. Hasselmo M.E., Linster C., Patil M., Ma D., Cekic M. Noradrenergic suppression of synaptic transmission may influence cortical signal-to-noise ratio. J. Neurophysiol. 1997, 77:3326-3339.
272. Adey W. A growing scientific consensus on the cell and molecular biology mediating interactions with EM fields 1994.
273. Buzsaki G. Rhythms of the Brain 2006, Oxford University Press, New York.
274. Strogatz S. Sync: The Emerging Science of Spontaneous Order 2003, Hyperion, New York.
275. Strogatz S.H. Exploring complex networks. Nature 2001, 410:268-276.
276. Iotti S., Borsari M., Bendahan D. Oscillations in energy metabolism. Biochim. Biophys. Acta 2010, 1797:1353-1361.
277. Strogatz S.H., Kronauer R.E., Czeisler C.A. Circadian pacemaker interferes with sleep onset at specific times each day: role in insomnia. Am. J. Physiol. 1987, 253:R172-R178.
278. Welsh J.P., Ahn E.S., Placantonakis D.G. Is autism due to brain desynchronization?. Int. J. Dev. Neurosci. 2005, 23:253-263.
279. Anderson G.M. Conceptualizing autism: the role for emergence. J. Am. Acad. Child Adolesc. Psychiatry. 2009, 48:688-691.
280. Anderson G.M. The potential role for emergence in autism. Autism Res. 2008, 1:18-30.
281. Sieb R.A. The emergence of consciousness. Med. Hypotheses 2004, 63:900-904.
282. Smith L.B., Thelen E. Development as a dynamic system. Trends Cogn. Sci. 2003, 7:343-348.
283. Custodio R.J., Junior C.E., Milani S.L., Simoes A.L., de Castro M., Moreira A.C. The emergence of the cortisol circadian rhythm in monozygotic and dizygotic twin infants: the twin-pair synchrony. Clin. Endocrinol. (Oxf) 2007, 66:192-197.
284. Herbert M. Emergent Systems Features 2012, AutismWHYandHOW.org.
285. Krueger J.M., Rector D.M., Roy S., Van Dongen H.P., Belenky G., Panksepp J. Sleep as a fundamental property of neuronal assemblies. Nat. Rev. Neurosci. 2008, 9:910-919.
286. Krueger J.M., Obal F. Sleep function. Front. Biosci. 2003, 8:d511-d519.
287. Juutilainen J., Kumlin T. Occupational magnetic field exposure and melatonin: interaction with light-at-night. Bioelectromagnetics 2006, 27:423-426.
288. Juutilainen J., Kumlin T., Naarala J. Do extremely low frequency magnetic fields enhance the effects of environmental carcinogens? A meta-analysis of experimental studies. Int. J. Radiat. Biol. 2006, 82:1-12.
289. Verschaeve L., Heikkinen P., Verheyen G., Van Gorp U., Boonen F., Vander Plaetse F., Maes A., Kumlin T., Maki-Paakkanen J., Puranen L., Juutilainen J. Investigation of co-genotoxic effects of radiofrequency electromagnetic fields in vivo. Radiat. Res. 2006, 165:598-607.
290. Ahlbom A., Bridges J., de Seze R., Hillert L., Juutilainen J., Mattsson M.O., Neubauer G., Schuz J., Simko M., Bromen K. Possible effects of electromagnetic fields (EMF) on human health-opinion of the scientific committee on emerging and newly identified health risks (SCENIHR). Toxicology 2008, 246:248-250.
291. Hoyto A., Luukkonen J., Juutilainen J., Naarala J. Proliferation, oxidative stress and cell death in cells exposed to 872MHz radiofrequency radiation and oxidants. Radiat. Res. 2008, 170:235-243.
292. Juutilainen J. Do electromagnetic fields enhance the effects of environmental carcinogens?. Radiat. Prot. Dosimetry. 2008, 132:228-231.
293. Luukkonen J., Hakulinen P., Maki-Paakkanen J., Juutilainen J., Naarala J. Enhancement of chemically induced reactive oxygen species production and DNA damage in human SH-SY5Y neuroblastoma cells by 872MHz radiofrequency radiation. Mutat. Res. 2009, 662:54-58.
294. Markkanen A., Juutilainen J., Naarala J. Pre-exposure to 50Hz magnetic fields modifies menadione-induced DNA damage response in murine L929 cells. Int. J. Radiat. Biol. 2008, 84:742-751.
295. King M., Bearman P. Diagnostic change and the increased prevalence of autism. Int. J. Epidemiol. 2009, 38:1224-1234.
296. Hertz-Picciotto I., Delwiche L. The rise in autism and the role of age at diagnosis. Epidemiology 2009, 20:84-90.
297. Herbert M.R., Weintraub K. The Autism Revolution: Whole Body Strategies for Making Life All It Can Be 2012, Random House with Harvard Health Publications, New York, NY.
298. Blank M. Electromagnetic fields. Pathophysiology 2009, 19(2-3).
299. The BioInitiative Report 2012: A Rationale for a Biologically-based Public Exposure Standard for Electromagnetic Fields (ELF and RF) 2012, http://www.bioinitiative.org/, C. Sage, D.O. Carpenter (Eds.).
300. Fragopoulou A., Grigoriev Y., Johansson O., Margaritis L.H., Morgan L., Richter E., Sage C. Scientific panel on electromagnetic field health risks: consensus points, recommendations, and rationales. Rev. Environ. Health. 2010, 25:307-317.
301. Sage C., Carpenter D.O. Public health implications of wireless technologies. Pathophysiology 2009, 16:233-246.
302. Roche R. CTIA Wireless Industry Indices Report Now available at:. http://blog.ctia.org/2012/05/17/indices-report/.
303. Cellular Telephone Industry of America (CTIA) Wireless Quick Facts: Midyear Figures 2012, Available at:. http://www.ctia.org/advocacy/research/index.cfm/aid/10323.
304. Reardon M. Emerging Markets Fuel Cell Phone Growth 2007, Available at:. http://news.cnet.com/Emerging-markets-fuel-cell-phone-growth/2100-1039-3615949.html.
305. Anonymous 2.14 Billion Cell Phone Subscribers in 2005 2005, Softpedia, May 20.
306. Sage C., Johansson O., Sage S.A. Response to comment on "Personal digital assistant (PDA) cell phone units produce elevated extremely-low frequency electromagnetic field emissions". Bioelectromagnetics 2007, 28:581-582.
307. International Agency for Research on Cancer of the World Health Organization IARC Classifies Radiofrequency Electromagnetic Fields as Possibly Carcinogenic to Humans 2011, May, International Agency for Research on Cancer of the World Health Organization, Lyons, France. http://www.iarc.fr/en/media-centre/pr/2011/pdfs/pr2208_E.pdf.
308. Baan R., Grosse Y., Lauby-Secretan B., El Ghissassi F., Bouvard V., Benbrahim-Tallaa L., Guha N., Islami F., Galichet L., Straif K. Carcinogenicity of radiofrequency electromagnetic fields. Lancet Oncol. 2011, 12:624-626.
309. Sage C., Johansson O., Sage S.A. Personal digital assistant (PDA) cell phone units produce elevated extremely-low frequency electromagnetic field emissions. Bioelectromagnetics 2007, 28:386-392.
310. Barouki R., Gluckman P.D., Grandjean P., Hanson M., Heindel J.J. Developmental origins of non-communicable disease: implications for research and public health. Environ. Health 2012, 11(42):1-9.
311. Derecki N.C., Cronk J.C., Lu Z., Xu E., Abbott S.B., Guyenet P.G., Kipnis J. Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature 2012, 484:105-109.
312. Derecki N.C., Cronk J.C., Kipnis J. The role of microglia in brain maintenance: implications for Rett syndrome. Trends Immunol. 2012.
313. Krakowiak P., Walker C.K., Bremer A.A., Baker A.S., Ozonoff S., Hansen R.L., Hertz-Picciotto I. Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders. Pediatrics 2012, 129:e1121-e1128.
314. Noble D. The Music of Life: Biology Beyond the Genome 2006, Oxford University Press, New York.
315. Herbert M. Autism: from static genetic brain defect to dynamic gene-environment modulated pathophysiology. Genetic Explanations: Sense and Nonsense 2013, 122-146. Harvard University Press, Cambridge, MA. S. Krimsky, J. Gruber (Eds.).
316. Cristofolini L., Taddei F., Baleani M., Baruffaldi F., Stea S., Viceconti M. Multiscale investigation of the functional properties of the human femur. Philos. Trans. A: Math. Phys. Eng. Sci. 2008, 366:3319-3341.
317. de Graaf A.A., Freidig A.P., De Roos B., Jamshidi N., Heinemann M., Rullmann J.A., Hall K.D., Adiels M., van Ommen B. Nutritional systems biology modeling: from molecular mechanisms to physiology. PLoS Comput. Biol. 2009, 5:e1000554.
318. Majumder D., Mukherjee A. A passage through systems biology to systems medicine: adoption of middle-out rational approaches towards the understanding of therapeutic outcomes in cancer. Analyst 2011, 136:663-678.
319. Vinga S., Neves A.R., Santos H., Brandt B.W., Kooijman S.A. Subcellular metabolic organization in the context of dynamic energy budget and biochemical systems theories. Philos. Trans. R. Soc. London, Ser. B 2010, 365:3429-3442.
320. Walker D.C., Southgate J. The virtual cell-a candidate co-ordinator for 'middle-out' modelling of biological systems. Brief. Bioinform. 2009, 10:450-461.
321. Mann K., Roschke J. Effects of pulsed high-frequency electromagnetic fields on human sleep. Neuropsychobiology 1996, 33:41-47.
322. Fragopoulou A., Margaritis L. Evidence for EMF Transcriptomics and Proteomics Research (2007-2012). The BioInitiative Report 2012: A Rationale for a Biologically-based Public Exposure Standard for Electromagnetic Fields (ELF and RF) 2012, (Section 5). http://www.bioinitiative.org/, C. Sage, D.O. Carpenter (Eds.).
323. Mumper E. Can awareness of medical pathophysiology in autism lead to primary care autism prevention strategies. N. Am. J Med. Sci. 2013, 6(3):134-144.